Search results
News Highlights: Top Company News of the Day - Thursday at 5 AM ET
Morningstar· 6 days agoShell's first-quarter adjusted earnings fell by less than expected, and the oil major kicked off a share buyback as it hurried to close the valuation gap to its U.S. rivals ...
Great performers constantly rehearse. Companies that want to survive sustained change must do the...
Fortune via Yahoo Finance· 14 hours agoCatalent works with many pharmaceutical companyies to make and deliver their products, including...
Analyst unveils Amgen stock price target after weight-loss drug data
TheStreet via Yahoo Finance· 4 days ago-based company reported first-quarter results on Thursday, including an update on its weight loss ...
5 ways to keep inflation from wrecking your retirement
Bankrate via AOL· 8 hours agoChasing higher yields to combat inflation can be a recipe for disaster, so be sure that you’re not...
Zhong Yuan Bio-Technology Holdings Ltd Plans $6 Million IPO for Week of May 6th (ZYB)
ETF DAILY NEWS· 6 days agoZhong Yuan Bio-Technology Holdings Ltd (ZYB) is planning to raise $6 million in an initial public offering on the week of May 6th, IPO Scoop reports. The company& ...
Dow Jones Rises As Disney Dives On Sales Miss; Palantir Plunges On Earnings
Investor's Business Daily· 14 hours agoShares were up 0.6% on the stock market today. Meanwhile, drug giant Merck is building a flat base...
Iovance (IOVA) stock price could jump by 30% after earnings
Invezz· 2 days agoIovance Biotherapeutics (NASDAQ: IOVA) stock price has rebounded sharply in the past few days as...
Earnings call: Intra-Cellular reports robust growth in CAPLYTA sales By Investing.com
Investing.com· 8 hours agoThe company reported total revenues of $144.9 million, a 53% surge compared to the same period in...
Novo Nordisk, ING, Shell: European Stocks in the Spotlight
The Wall Street Journal· 5 days ago↘️ **Novo Nordisk (DK: NOVO.B**, **NVO)**: Europe's most valuable company raised its annual guidance...
Why Things Are Looking Up For IBD Stock Of The Day Neurocrine, A Top 1% Biotech
Investor's Business Daily· 6 days agoThe company is testing that drug, dubbed NBI-1065845, in patients with hard-to-treat depression....